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Abstract 
Objective: Septic shock is characterized for hypotension and multiple organ failures after 
infection by microorganisms. Septic patients exhibit high levels of circulating microparticles, 
small vesicles released from plasma membrane of activated or apoptotic cells. Here, we have 
investigated the effects of in vivo injection of microparticles from nonseptic or septic subjects 
on protein expression in mice tissues. 
Design: Prospective, controlled experiments. 
Setting: Animal basic science laboratory. 
Subjects: Male Swiss mice were assigned randomly to one of two groups: 11 animals injected 
with microparticles isolated from healthy subjects, and 15 animals injected with 
microparticles isolated from septic patients. 
Interventions: Microparticles were extracted from whole blood of septic and nonseptic 
subjects and were i.v. injected in mice. After 24 hours, mice were sacrificed and heart, lungs, 
liver and kidneys were isolated for western blots assays. Also, organs were used for direct 
measure of nitric oxide (NO) and superoxide anion (O2
-
) productions by electron 
paramagnetic resonance. 
Measurements and Main Results: In heart and lungs, microparticles from septic shock patients 
increased expressions of endothelial and inducible NO-synthases, cyclo-oxygenase-2 and NF-
κB. Only extracellular superoxide dismutase (SOD) expression was increased in heart. These 
effects were associated either with a greater oxidative or nitrative stress in heart and lungs, 
respectively, without affecting NO production. Liver exhibited an increase in oxidative stress 
linked to decreased endothelial NO-synthase and Mn-SOD expressions. However, cyclo-
oxygenase 2 expression and IκBα phosphorylation were decreased. Septic microparticles did 
not change O2
-
 and NO productions in kidneys. 
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Conclusions: Altogether, these data suggest that microparticles from septic shock patients 
exert pleiotropic and differential effects depending on targets tissues with regard to the 
expression of pro-inflammatory proteins related with nitrative and oxidative stresses and they 
might participate in organ dysfunction observed in septic shock patients. 
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INTRODUCTION 
Sepsis, the host response to infection, may lead to severe sepsis that is associated with 
evidence of organ dysfunction as a consequence of the combination of severe inflammation 
and secondary changes in endocrine profile. During this phase, the cardiovascular system 
adopts a high cardiac output state with low peripheral resistance hemodynamic profile, and 
hypotension that is refractory to catecholamines despite adequate volume resuscitation, and 
contributes to life-threatening organ failure during septic shock (1, 2). Release of reactive 
oxygen species (ROS) by different pathways contributes to the failure of organ such as lung, 
heart, liver and kidney. Indeed, there is a considerable body of evidence for redox imbalance 
and oxidative stress in sepsis demonstrated by increased markers of oxidative damage (for 
review see 3, 4). 
Besides, the activation of a number of host mediator systems, including the cytokine, 
leukocyte, and hemostatic networks may lead to overproduction of nitric oxide (NO). Large 
amounts of NO, generated by enhanced expression of the inducible NO synthase (iNOS) have 
been detected in human vessels from septic patients (5) and from endotoxinic rats (6), and are 
implicated in symptoms observed in septic shock patients and animals, including tissue 
hypoperfusion and hypoxia, lactic acidosis, oliguria and vascular hyporeactivity. 
Recently, it has been shown that microparticles (MPs) derived from the plasma of malaria-
infected mice induce potent activation of macrophages in vitro and may contribute to malaria 
infection-induced inflammation (7). Also, Soriano et al. (8) have shown that MPs could be 
considered as markers of inflammation in patients with septic shock. Moreover, Niewland et 
al (9) have reported elevated levels of circulating MPs in meningococcal sepsis. MPs are 
small vesicles shed from the blebbing plasma membrane of various cell types during 
activation or apoptosis (10). Recently, we have shown that circulating MPs are significantly 
increased in septic patients compared to nonseptic subjects and in particular, platelet- and 
5 
 
endothelial-derived MPs, as well as, L-selectin
+
 and P-selectin
+
 MPs (11). Furthermore, MPs 
from septic patients are rather protective against vascular hyporeactivity in order to maintain 
vasoconstrictive response in mice treated with LPS (11). To the best of our knowledge, the 
role played by MPs in different target organs has not been assessed although they regulate 
vascular function in septic shock patients. Moreover, their role with regard to tissular changes 
either of oxidative or nitrative stress during sepsis is not known. Therefore, the aim of the 
present study is to assess the in vivo pathophysiological relevance of MPs after they were i.v. 
injected into mice, with respect to NO and O2
-
 productions in heart, liver, lungs and kidneys. 
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Materials and methods 
Patients and blood cell preparation 
This study was approved by the Ethics committee of the Société de Réanimation de Langue 
Française. The study included patients with (n = 15) or without (n = 11) septic shock. Septic 
shock was defined according to standard criteria of American college of chest 
physicians/Society of Critical Care Medicine Consensus Conference, 1992. Baseline 
characteristic of patients with septic shock (male: 93%, female: 7%) are shown in Table 1. 
Also, the sources of sepsis are shown in Table 1. Patients without evidence of infection and 
with normal hemodynamics were considered as controls (male: 73%, female: 27%). 
Peripheral blood (20 mL) from nonseptic and septic patients was collected during the early 
phase of septic shock (10 ± 4 hours after enrollment in the intensive care unit) from a 
peripheral vein. MPs were isolated and MPs subpopulations were discriminated according the 
expression of membrane-specific antigens and samples were analyzed in a MXP (Beckman 
Coulter) as previously reported (11). The MPs concentration for injection was determined by 
flow cytometry. As previously described (11), septic patients displayed elevated circulating 
levels of MPs from platelets and endothelial cells, and those expressing CD62L and CD62P. 
Levels of endotoxin were assessed in all MP preparations with a Limulus amebocyte lysate kit 
(QCL-1000; Lonza, Walkersville, MD) and were found to be below the lower detection limit 
of the kit (<0.1 endotoxin unit/mL). 
NO determination by electron paramagnetic resonance (EPR) 
All animal studies were carried out using approved institutional protocols and were 
conformed the Guide for the Care and Use of Laboratory Animals published by US National 
Institutes of Health (NIH Publication No. 85-23, revised 1996). Male Swiss mice (8-10 weeks 
old) were treated in vivo by injection into the tail vein of MPs at the circulating levels of MPs 
detected in the blood of septic or nonseptic patients (range: 1,451 – 69,485 MPs/microliter of 
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plasma), as previously described (11). It should be noted that independently of the circulating 
level, all septic MPs displayed hyperreactivity in aortic rings (11). Under these conditions, we 
did not see any mortality or clinical signs of sepsis in injected mice. 
Hearts, livers, lungs and kidneys were obtained from mice treated either with MPs from 
nonseptic or septic patients during 24 hours. Then, tissues were dissected and incubated for 30 
minutes in Krebs-Hepes buffer containing: BSA (20.5 g/L), CaCl2 (3 mM) and L-arginine 
(0.8 mM) in order to assess NO production. Fe(DETC)2 solution was added to organs and 
incubated for 45 minutes at 37°C. Then, organs were immediately frozen using liquid N2. NO 
measurement was performed on a table-top x-band spectrometer Miniscope (Magnettech, 
MS200, Berlin, Germany) as previously described (11). Values are expressed in unit/mg 
weight of dried tissue. 
Superoxide anion spin-trapping 
After sacrifice of mice pre-treated with nonseptic and septic MPs, heart, liver, lungs and 
kidneys were allowed to equilibrate in deferoxamine-chelated Krebs-Hepes solution 
containing 1-hydroxy-3methoxycarbonyl-2,2,5,5-tetramethylpyrrolidin (CMH, Noxygen, 
Germany) (500 M), deferoxamine (25 M) and DETC (5 M) under constant temperature 
(37°C) for 45 minutes. Samples were then frozen in liquid N2 and analyzed by EPR. Values 
are expressed in unit/mg weight of dried tissue. 
Western Blotting 
After treatment, tissues were homogenized and lysed. Proteins (80 µg) were separated on 10 
% SDS-PAGE. Blots were probed with anti-endothelial NOS (eNOS), anti-inducible NOS 
(iNOS), anti-cyclooxygenase-2 (COX-2) (BD Biosciences, San Jose, CA), anti-
cyclooxygenase-1 (COX-1) (Santa Cruz Biotechnology, Santa Cruz, CA), anti-p65 subunit of 
nuclear factor-κB (NF-κB) (Abcam, Cambridge, UK), anti-phospho-IκB alpha (p-IκBα) (US 
Biological, Swampscott, MA), anti-Mn superoxide dismutase (Mn-SOD), anti-copper/zinc 
8 
 
superoxide dismutase (Cu/Zn-SOD), anti-extracellular superoxide dismutase (EC-SOD) 
(Stressgen Biotechnologies Corporation, Victoria, Canada) and anti-nitrotyrosine (Cayman 
Chemical, Ann Arbor, MI) antibodies. A polyclonal rabbit anti-β-actin antibody (Sigma-
Aldrich, St Quentin Fallavier, France) was used for visualization of protein gel loading. The 
membranes were then incubated with the appropriate horseradish peroxidase-conjugated 
secondary antibody (Amersham Biosciences, Piscataway, NJ), and the protein-antibody 
complexes were detected by Enhanced chemiluminescence plus (Amersham Biosciences). 
Data analysis 
Data are represented as mean ± SEM, n represents the number of animals. Statistical analyses 
were performed by two-way analysis of variance or nonparametric Mann-Whitney U tests 
depending on the number of samples. P<0.05 was considered to be statistically significant. 
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Results 
 Effects of MPs on protein expression in heart. Hearts taken from mice treated with 
septic MPs exhibited enhanced expressions of enzymes related to NO and prostanoid 
productions, namely eNOS and iNOS, COX-1 and COX-2, compared with that taken from 
nonseptic MP-treated mice. These effects were associated with an increase in NF-κB 
expression without modification of p-IκBα. Concerning the enzymes implicated in oxidative 
stress, treatment with septic MPs elicited a greater expression of EC-SOD but not Cu/Zn-SOD 
nor Mn-SOD (Fig. 1). 
 Effects of MPs on protein expression in lungs. In lungs from septic MP-treated mice 
(Fig. 2), eNOS expression was increased, as well as, expression of inducible proteins, iNOS 
and COX-2 but not that of COX-1. In addition, NF-κB expression was augmented whereas p-
IκBα was significantly reduced. No effects on SOD protein expressions were observed in 
lungs treated with MPs from septic patients. 
 Effects of MPs on protein expression in liver. As shown in Fig. 3, livers from septic 
MP-treated mice exhibited lower expressions of eNOS and COX-2. Expressions of iNOS, 
COX-1 and NF-κB were not modified in livers from septic MP-treated mice compared with 
that from nonseptic-treated mice. Moreover, p-IκBα was significantly reduced. Although MPs 
from septic patients induced a slight, but significant, decrease in Mn-SOD expression, the 
other SOD proteins were not modified. 
 Effects of MPs on protein expression in kidneys. As shown in Fig. 4, kidneys from 
septic MP-treated mice exhibited a significant decrease of eNOS expression, while those of 
COX-1, iNOS and COX-2 were not modified. Among other proteins studied, only p-IκBα 
was reduced and Cu/Zn-SOD was increased in response to septic MP treatment. 
 Effects of MPs on tissue NO and O2
-
 production and nitrative stress. NO measurement 
by EPR showed that septic MPs did not affect NO production, in heart, liver, lungs and 
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kidneys, compared with nonseptic MP-treated mice. Regarding oxidative stress, O2
-
 
production was greater in heart and liver but not in lungs and kidneys from mice treated with 
septic MPs versus nonseptic MPs (Fig. 5). 
The reaction between NO and O2
-
 generates peroxynitrite. Then, we evaluated its formation in 
tissues by studying nitration of proteins, a subsequent step to peroxynitrite formation, using 
specific antibodies raised against nitrotyrosine. Interestingly, septic MPs strongly increased 
nitration of proteins in lungs, but not in other tissues (heart, liver and kidneys) (Fig. 6). 
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Discussion 
The present study show that i.v. injection of MPs obtained from septic shock patients, at an 
early septic stage, into mice exerts differential effects on target tissues of such as heart, liver, 
lungs, and kidneys with regard to proteins related to NO release and O2
-
 production, as well as 
COX. Thus, heart and lungs were the most affected with respect to increased expression of 
pro-inflammatory proteins (iNOS, COX-2 and NF-κB pathway) but not those of SOD isoform 
except that of EC-SOD in the heart. These effects were associated either with a greater 
oxidative or nitrative stress in heart and lungs, respectively, without affecting tissular NO 
production. Liver exhibited an increase in oxidative stress linked with decreased eNOS and 
Mn-SOD despite reduced expression of COX-2 and phosphorylation of IκBα. Finally, kidneys 
were the least affected inasmuch septic MPs did not change O2
-
 and NO productions.  
Recently, we reported increased circulating levels of MPs in patients with septic shock 
compared to nonseptic patients (11). In the present study, we provide evidence that 
heterologous injection in mice of MPs obtained from septic shock patients compared to 
injection of MPs obtained from non-septic shock patients may induce deleterious effects in 
different target tissues including heart, lung and livers in terms of oxidative and nitrative 
stresses despite the fact that they may, rather, be protective in counteracting the drop in 
peripheral resistance and progressive hypotension during severe sepsis (11), under the 
experimental conditions used. Very recently, we found that rats with sepsis induced by 
peritonitis exhibit a specific phenotype of MPs, being MPs from leukocytes increased. 
Inoculation of these MPs in healthy rats reproduced hemodynamic, septic inflammatory 
patterns, associated with oxidative and nitrative stresses in heart and aorta (12). Although, 
septic MPs from human (11 ) or rats (12) exert different effect in terms of oxidative and 
nitrative stresses in aorta, they exhibit similar effects in the heart. 
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Whereas constitutive NOS appears to be involved in the physiological regulation of 
myocardial contractility through interaction between endothelial cells and cardiac myocytes 
(13), iNOS is responsible for the larger component of the prolonged myocardial depression 
during sepsis. Upon septic MP treatment, no increase in NO level was detected in the heart 
despite eNOS and iNOS over-expressions. In this tissue, it is possible that the strong increase 
in O2
-
 production induced by septic MPs decreases the bioavailability of NO, as we previously 
described in metabolic syndrome (14). Also, uncoupling of NOS may explain the lack of 
detection of NO production. In fact, both eNOS and iNOS uncoupling can contribute to 
increase in O2
-
 levels (15, 16). Thus in heart, enhanced expression of the two isoforms of NOS 
by septic MPs may account for the increase in O2
-
 but not NO production. We have previously 
shown that injection of MPs isolated from rats with peritonitis increased both NO and O2
-
 in 
MP-inoculated rats (12). These discrepancies suggest that the different origin of MPs 
(peritonitis in rats vs pulmonary infection mainly in septic patients) could account for the 
different regulation of NO production. Nevertheless, the cellular targets of septic MPs 
remained to be determined whether they originated from cardiomyocytes or inflammatory 
cells infiltrated in the myocardium.  
In lungs, we can speculate that the scavenging of NO by O2
-
 to produce peroxynitrite is a key 
mechanism that decreases NO bioavailability in lungs. This hypothesis is confirmed by the 
increase in nitration of proteins in lungs from mice treated with septic MPs. It was shown that 
several proteins (72, 42, 35, 31, 25, 9 Kda) were nitrated in lungs from mice treated with 
septic MPs. Although the identity of these proteins has not been assessed, their molecular 
weights were similar to those of COX-2, actin or ERK MAP kinase, MnSOD, caveolin and 
ubiquitin. Indeed, nitration of these proteins may have critical consequences in 
pathophysiology of the lung during sepsis.  
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In addition, in heart as well as in lungs, COX-2 expression was increased. Indeed, COX-2 is 
over-expressed in heart from septic rats and this is associated with heart injury (17). Also in 
septic shock rats, COX-2 metabolites are involved in the alterations of L-type calcium 
currents observed in myocytes (18). Marshall and collaborators (19) have shown an increased 
COX-2 levels in lungs from lipopolysaccharide-injected rats. Altogether, these results suggest 
that septic MPs may be responsible, at least in part, of the over-expression of COX-2 
described in heart and lungs during sepsis and they may account for the deleterious effects of 
COX metabolites in these tissues. 
The hepatic dysfunction and acute renal failure occur in the first hours after the initial injury 
as result of a decrease of portal and hepatic blood flows (20, 21). Although it is established 
that iNOS is induced in the liver and kidney during septic shock (22, 23), injection of septic 
MPs in mice neither affected NO production nor iNOS expression in liver, even both eNOS 
and COX-2 expressions were reduced. eNOS deficiency increases susceptibility to acute renal 
failure during sepsis (25). Thus, septic MPs may have a deleterious effect on hepatic and renal 
function by acting on endothelial level although they did not affect tissular production of NO. 
Despite no changes or decrease on I-κBα phosphorylation has been observed in all tissues, 
NF-κB, iNOS and COX-2 expressions are increased in heart and lungs. It is possible that 
activation of I-κBα might be delayed compared to activation of downstream proteins or that 
upregulation of iNOS and COX-2 observed in tissues from mice treated with septic MPs 
involves transcription factor different to NF-κB. 
Regarding the enzymes controlling oxidative stress, expression of EC-SOD was strongly 
increased in heart treated with septic MPs, and this was associated with O2
-
 overproduction. 
EC-SOD is the only anti-oxidant enzyme that scavenges O2
-
 specifically in the extracellular 
compartment. The fact that O2
-
 levels increase concomitantly to the enhancement of EC-SOD 
suggests that the overproduction of O2
-
 might induce an up-regulation of EC-SOD expression 
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in order to compensate the increase in oxidative stress. Other explanation is that the gain of 
EC-SOD function can be associated with deleterious effects as observed in other models. 
Indeed, the gain of SOD function is accompanied to motor neuron disease in transgenic mice 
(26) and atherosclerotic plaque development in ApoE-/- and LDL-/- mice (27). In the liver, 
septic MPs significantly increased O2
-
 levels along with a slight reduction of Mn-SOD 
expression. Since Mn-SOD is mainly expressed in mitochondria, it is plausible to hypothesize 
that this organelle plays a role in the control of oxidative stress in liver. Septic MPs did not 
modify O2
-
 production in the kidney despite an increase of Cu/Zn-SOD strengthened the 
notion that this organ is the least affected. 
Limitations of the Study. We have reported that MPs may be protective against vascular 
hyporeactivity by maintaining a vasoconstrictive response in patients with septic shock (11). 
In the present study, we show, under the same experimental conditions, that septic MPs can 
induce oxidative and nitrative stresses and increase expression of pro-inflammatory enzymes 
in some of target tissues being heart and lungs the most affected. The reasons of the 
differential effects of MPs might be due to tissue distribution, metabolism or the nature of the 
target cells. In addition, it should be noted that the increase of nitration of proteins might 
imply not only an increase on peroxynitrite production, but also an enhanced activity of 
peroxidase enzymes, such as myeloperoxidases. Also, the effects of septic MPs on proteins 
implicated in coagulation have not been explored, although it is well established that MPs 
carry tissue factor and that in sepsis activation of coagulation has been described (28). Further 
studies are needed to sort out these underlying mechanisms. Nevertheless, we can conclude 
that MPs might participate in organ dysfunction observed in septic shock patients despite the 
reported correlation between increased circulating MPs and better survival rate among 
patients in the early phase of septic shock (8). 
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TABLE 1: Baseline characteristics of non-septic and septic patients. 
 Non-septic patients 
(n=11) 
Septic patients 
(n=15) 
Age (years) 42 ± 17 63 ± 13 
Sex ratio (M/F) 8/3 14/1 
Mean infusion rate of 
norepinephrine 
0 0.8 ± 0.8 µg/kg/min 
Mortality at 28 days 0 33% 
SAPS II 0 57 ± 19 
SOFA score 0 10.8 ± 3.8 
Body mass index (kg/m
2
) 23 ± 3 28 ± 10 
Mean arterial pressure (mmHg)  73.5 ± 4.6 
Heart rate/min  95 ± 5 
Source of infection   
Pulmonary  47% 
Abdominal  27% 
Soft tissue  20% 
Urinary  0% 
Unknown  6% 
Type of infection   
gram-positive cocci  5 
gram-positive bacillus  1 
gram-negative bacillus  4 
Not identified  5 
Treatments before admission   
Beta-blockers 0/11 5/15 
ACE inhibitor 0/11 2/15 
Calcium blockers 0/11 2/15 
Diuretics 0/11 3/15 
Statins 0/11 3/15 
Antithrombotic/antiaggregrant 0/11 7/15 
Proton pump inhibitor 2/11 4/15 
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Antibiotics 0/11 3/15 
Anti-depressants 0/11 5/15 
Treatments during 
hospitalization 
  
Benzodiazepines  13/15 
Morphine  9/15 
Anesthetics  4/15 
Curare  7/15 
Norepinephrine/epinephrine  11/15 
Antibiotics  15/15 
Activated C protein  6/15 
Insulin  12/15 
Hydrocortisone  13/15 
Definition of abbreviations: ACE = Angiotensin-converting enzyme; SAPS = simplified acute 
physiology score; SOFA = sequential organ failure assessment. 
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Legend of figures 
Figure 1. Effects of microparticles from nonseptic (NonSMPs) or septic (SMPs) subjects on 
protein expression in heart. Mice were injected with MPs for 24 h and then, they were 
sacrificed and heart isolated for analysis of protein expressions. Blots were probed with anti-
eNOS, anti-iNOS, anti-COX-1, anti-COX-2, anti-NF-κB, anti-p-IκBα, anti-Cu/Zn-SOD, anti-
Mn-SOD or anti-EC-SOD antibodies. Data are representative of nine separate blots, and the 
densitometry values are expressed in arbitrary units (AU) as mean ± S.E.M. ** P < 0.01, *** 
P < 0.001 vs. NonSMPs. 
 
Figure 2. Effects of microparticles from nonseptic (NonSMPs) or septic (SMPs) subjects on 
protein expression in lungs. Mice were injected with MPs for 24 h and then, they were 
sacrificed and lungs isolated for analysis of protein expressions. Blots were probed with anti-
eNOS, anti-iNOS, anti-COX-1, anti-COX-2, anti-NF-κB, anti-p-IκBα, anti-Cu/Zn-SOD, anti-
Mn-SOD or anti-EC-SOD antibodies. Data are representative of nine separate blots, and the 
densitometry values are expressed in arbitrary units (AU) as mean ± S.E.M. * P < 0.05, ** P 
< 0.01, *** P < 0.001 vs. NonSMPs. 
 
Figure 3. Effects of microparticles from nonseptic (NonSMPs) or septic (SMPs) subjects on 
protein expression in liver. Mice were injected with MPs for 24 h and then, they were 
sacrificed and liver isolated for analysis of protein expressions. Blots were probed with anti-
eNOS, anti-iNOS, anti-COX-1, anti-COX-2, anti-NF-κB, anti-p-IκBα, anti-Cu/Zn-SOD, anti-
Mn-SOD or anti-EC-SOD antibodies. Data are representative of nine separate blots, and the 
densitometry values are expressed in arbitrary units (AU) as mean ± S.E.M. * P < 0.05, ** P 
< 0.01 vs. NonSMPs.  
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Figure 4. Effects of microparticles from nonseptic (NonSMPs) or septic (SMPs) subjects on 
protein expression in kidneys. Mice were injected with MPs for 24 h and then, they were 
sacrificed and kidneys isolated for analysis of protein expressions.  Blots were probed with 
anti-eNOS, anti-iNOS, anti-COX-1, anti-COX-2, anti-NF-κB, anti-p-IκBα, anti-Cu/Zn-SOD, 
anti-Mn-SOD or anti-EC-SOD antibodies. Data are representative of nine separate blots, and 
the densitometry values are expressed in arbitrary units (AU) as mean ± S.E.M. ** P < 0.01, 
*** P < 0.01 vs. NonSMPs. 
Figure 5. Effects of microparticles on tissue NO and O2
-
 production. Quantification of the 
amplitude of NO-Fe(DETC)2 (A) O2
-
-CMH (B) signals in mouse tissues treated with either 
nonseptic (NonSMPs) or septic (SMPs) microparticles. Values are expressed in units/mg 
weight of dried tissues as mean ± S.E.M. (n= 3-4). * P < 0.05 vs. NonSMPs. 
 
Figure 6. Effects of nonseptic (NonSMPs) and septic (SMPs) microparticles on nitration of 
proteins. (A) Western blot showing tyrosine nitration in lungs. (B) Immunoblots from heart, 
lungs, liver, and kidneys were quantified by densitometric analysis. Data are representative of 
four separate blots, and the densitometry values are expressed in arbitrary units (A.U.) as 
mean ± SEM. * P < 0.05 vs. NonSMPs. 
